Overview

MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
A study to determine lipid changing effects of MK0524A when compared to niacin extended release (NIASPAN) and placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Niacin
Niacinamide
Nicotinic Acids